University of Wisconsin Hospitals and Clinics Neuromuscular Medicine (Neurology)

Topics

• Neurogenetic and Muscular Disorders Research 20
• Lysosomal Storage Disorders Research 16
• Alzheimer's disease research and treatments 7
• Muscle Physiology and Disorders 6
• Hereditary Neurological Disorders 4
• Neonatal and fetal brain pathology 4
• Peripheral Nerve Disorders 4
• Amyotrophic Lateral Sclerosis Research 2
• Autoimmune Neurological Disorders and Treatments 2
• Cardiac Ischemia and Reperfusion 2
• Congenital Heart Disease Studies 2
• Metabolism and Genetic Disorders 2

Most cited

1. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial.

   The Lancet. Neurology · 2021 · 399 citations · Jennifer Kwon

2. Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.

   Nature medicine · 2022 · 263 citations · Jennifer Kwon

3. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.

   Nature medicine · 2022 · 236 citations · Jennifer Kwon

4. An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy.

   Annals of clinical and translational neurology · 2022 · 31 citations · Jennifer Kwon

5. Newborn Screening for Spinal Muscular Atrophy: Variations in Practice and Early Management of Infants with Spinal Muscular Atrophy in the United States.

   International journal of neonatal screening · 2024 · 18 citations · Cameron Crockett

6. Expert recommendations and clinical considerations in the use of onasemnogene abeparvovec gene therapy for spinal muscular atrophy.

   Muscle & nerve · 2021 · 47 citations ·